摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

cyclohexa[1,2-d]-2,3,3a,11a-tetrahydro-3-hydroxy-2-hydroxymethyl-10H-furo[2',3':4,5]oxazolo[3,2-a]pyrimidin-10-one | 1215184-85-2

中文名称
——
中文别名
——
英文名称
cyclohexa[1,2-d]-2,3,3a,11a-tetrahydro-3-hydroxy-2-hydroxymethyl-10H-furo[2',3':4,5]oxazolo[3,2-a]pyrimidin-10-one
英文别名
(11R,13R,14R,15S)-14-hydroxy-13-(hydroxymethyl)-12,16-dioxa-2,10-diazatetracyclo[8.6.0.03,8.011,15]hexadeca-1,3(8)-dien-9-one
cyclohexa[1,2-d]-2,3,3a,11a-tetrahydro-3-hydroxy-2-hydroxymethyl-10H-furo[2',3':4,5]oxazolo[3,2-a]pyrimidin-10-one化学式
CAS
1215184-85-2
化学式
C13H16N2O5
mdl
——
分子量
280.28
InChiKey
SSWSVUANSUPVIV-MWGHHZFTSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0
  • 重原子数:
    20
  • 可旋转键数:
    1
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.69
  • 拓扑面积:
    91.6
  • 氢给体数:
    2
  • 氢受体数:
    6

反应信息

  • 作为反应物:
    描述:
    cyclohexa[1,2-d]-2,3,3a,11a-tetrahydro-3-hydroxy-2-hydroxymethyl-10H-furo[2',3':4,5]oxazolo[3,2-a]pyrimidin-10-onesodium ethanolate盐酸 作用下, 以 乙醇 为溶剂, 以13%的产率得到3-[3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-5,6,7,8-tetrahydroquinazoline-2,4(1H,3H)-dione
    参考文献:
    名称:
    Synthesis and in vitro cytostatic activity of new β - d -arabino furan[1′,2′:4,5]oxazolo- and arabino-pyrimidinone derivatives
    摘要:
    A series of nucleoside derivatives was obtained via heteroatom annulation of the amino oxazoline Of D(-)-arabinose. Unequivocal proofs for the stereostructure of some new arabinosyl pyrimidinone derivatives were obtained by X-ray structure analysis. These newly synthesized compounds were then evaluated for their cytostatic activity against murine leukemia (L1210), and human T-lymphocytes (Molt 4/C8 and CEM). Of all the compounds in the series, the protected silylated tricyclic fused pyrimidinone 10 showed the most significant antitumor activity against murine leukemia L1210 (IC50 = 6 mu M), and human T-lymphocytes cells Molt 4/C8 (IC50 = 7.9 mu M) and CEM/0 cell lines (IC50 = 7.5 mu M). None of the compounds exhibited significant antiviral inhibitory activities. (C) 2009 Elsevier Masson SAS. All rights reserved.
    DOI:
    10.1016/j.ejmech.2009.10.032
  • 作为产物:
    描述:
    cyclohexa[1,2-d]-2,3,3a,11a-tetrahydro-3-(O-tertbutyldimethylsilyl)-2-(O-tert-butyldimethylsilylmethyl)-10H-furo[2',3':4,5]oxazolo[3,2-a]pyrimidin-10-one四丁基氟化铵 作用下, 以 四氢呋喃 为溶剂, 反应 0.33h, 以80%的产率得到cyclohexa[1,2-d]-2,3,3a,11a-tetrahydro-3-hydroxy-2-hydroxymethyl-10H-furo[2',3':4,5]oxazolo[3,2-a]pyrimidin-10-one
    参考文献:
    名称:
    Synthesis and in vitro cytostatic activity of new β - d -arabino furan[1′,2′:4,5]oxazolo- and arabino-pyrimidinone derivatives
    摘要:
    A series of nucleoside derivatives was obtained via heteroatom annulation of the amino oxazoline Of D(-)-arabinose. Unequivocal proofs for the stereostructure of some new arabinosyl pyrimidinone derivatives were obtained by X-ray structure analysis. These newly synthesized compounds were then evaluated for their cytostatic activity against murine leukemia (L1210), and human T-lymphocytes (Molt 4/C8 and CEM). Of all the compounds in the series, the protected silylated tricyclic fused pyrimidinone 10 showed the most significant antitumor activity against murine leukemia L1210 (IC50 = 6 mu M), and human T-lymphocytes cells Molt 4/C8 (IC50 = 7.9 mu M) and CEM/0 cell lines (IC50 = 7.5 mu M). None of the compounds exhibited significant antiviral inhibitory activities. (C) 2009 Elsevier Masson SAS. All rights reserved.
    DOI:
    10.1016/j.ejmech.2009.10.032
点击查看最新优质反应信息